These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Chen MY; Lie PC; Li ZL; Wei X Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653 [TBL] [Abstract][Full Text] [Related]
3. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Tian Y; Deng YB; Huang YJ; Wang Y Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798 [TBL] [Abstract][Full Text] [Related]
5. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Miao Z; Jin J; Chen L; Zhu J; Huang W; Zhao J; Qian H; Zhang X Cell Biol Int; 2006 Sep; 30(9):681-7. PubMed ID: 16870478 [TBL] [Abstract][Full Text] [Related]
6. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691 [TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets. Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330 [TBL] [Abstract][Full Text] [Related]
9. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Le Blanc K; Ringdén O Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285 [TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord mesenchymal stem cells: osteogenesis in vivo as seed cells for bone tissue engineering. Diao Y; Ma Q; Cui F; Zhong Y J Biomed Mater Res A; 2009 Oct; 91(1):123-31. PubMed ID: 18767055 [TBL] [Abstract][Full Text] [Related]
11. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2. Zhao L; Li G; Chan KM; Wang Y; Tang PF Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus. Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894 [TBL] [Abstract][Full Text] [Related]
13. Xenogeneic immunosuppression of human umbilical cord mesenchymal stem cells in a major histocompatibility complex-mismatched allogeneic acute graft-versus-host disease murine model. Guo J; Yang J; Cao G; Fan H; Guo C; Ma YE; Qian Y; Chen L; Li X; Chang C Eur J Haematol; 2011 Sep; 87(3):235-43. PubMed ID: 21535158 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells and their potential as cardiac therapeutics. Pittenger MF; Martin BJ Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981 [TBL] [Abstract][Full Text] [Related]
15. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052 [TBL] [Abstract][Full Text] [Related]
17. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models]. Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667 [TBL] [Abstract][Full Text] [Related]
18. [The effect of co-transplantation of bone marrow-derived mesenchymal stem cells and islet on maturation and function of bone marrow-derived dendritic cells in recipient mice]. Li FR; Deng CY; Wang XG; Qi H; Ren LL; Zhou HX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):646-9. PubMed ID: 20619087 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750 [TBL] [Abstract][Full Text] [Related]
20. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]